Diamond Equity Research Initiates Coverage on Altamira Therapeutics Ltd. (NASDAQ: CYTO)

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Altamira Therapeutics Ltd. (NASDAQ:CYTO). The in-depth 28-page initiation report includes detailed information on the Altamira Therapeutic's business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include:    Altamira's Delivery Platforms to Pote ...